Location: Home
  • search
  • go
  • Relate News
  • 5/29/2025China Approves Zelgen's Gecacitinib
  • 5/29/2025China Grants Conditional Approval to Hengrui's Famitinib
  • 5/29/2025Livzon Acquires Majority Stake in Vietnam's Imexpharm for $221 Million
  • 5/29/2025Rona Unveils Promising Preclinical Data for Annual RNAi Therapy
  • 5/29/2025AusperBio Secures $50M in Series B+ Financing
  • 5/29/2025CDE Issues Guideline on Safety Assessment and Reporting in Pediatric D...
  • 5/29/2025CDE Launches “Starlight Plan” to Encourage Pediatric Antitumor Drug ...
  • 5/29/2025CDE Issues Guideline on Production Site Change Research for Licensed B...
  • 5/29/2025CDE Solicits Comments on Draft Technical Considerations for NMR Studi...
  • 5/29/2025First Patient Dosed in YK012 Trial -The World's First TCE Therapy for ...
  • 5/28/2025Novartis Broadens Alliance with Shanghai Pharma to Include Eye Drugs i...
  • 5/28/2025Vigene and Merz Expand Strategic Partnership Across Greater China
  • 5/27/2025XellSmart's iPSC-Derived Cell Therapy for Spinal Cord Injury Advances ...
  • 5/27/2025CTTQ's Anlotinib Combination Shows Promise
  • 5/27/2025Henlius Reports Promising Phase 1 Results for PD-L1-Targeting ADC HLX4...
  • 5/27/2025Insilico Medicine Unveils AI-Designed ENPP1 Inhibitor ISM5939
  • 5/27/2025Zai Lab's ZL-1310 Shows Promising Results in Extensive-Stage SCLC
  • 5/27/2025Innovent's Mazdutide Demonstrates Significant Weight Loss in Phase 3 G...
  • 5/27/2025Servier Acquires BioNova's Menin Inhibitor BN104
  • 5/27/2025Recce Pharma Secures Key China Patent
  • 5/27/2025FDA Approves China's First Homegrown Painkiller Qamzova
  • 5/27/2025Juri Bio Secures Global Rights to Novel Prostate Cancer Immunotherapy ...
  • 5/27/2025Sinotau Files for HK IPO to Advance Radiopharma Innovations
  • 5/27/2025RemeGen's Telitacicept Gains Approval in China
  • 5/27/2025Salubris Pharma's S086 Receives Chinese Approval for Hypertension Trea...
  • 5/27/2025DualityBio's HER3-Targeted ADC DB-1310 Shows Promising Early Results i...
  • 5/27/2025PegBio Debuts on HKEx, Raising HK$300M to Advance GLP-1 Therapies
  • 5/27/2025Eisai's Dayvigo Receives Approval in China for Insomnia
  • 5/27/2025Hengrui's c-MET-Targeted ADC SHR-1826 Shows Promising Results in Phase...
  • 5/27/2025Salubris Invests CNY 550M in Next-Gen Hypertension siRNA Therapy with ...
  • Page:3/770 Total number of articles:23089: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group